MedSci Healthcare Holdings Ltd.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: KYG5960J1085

HKD

1.23

0.01 (0.82%)

Apr 02

HKG

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

EC Healthcare

ADICON Holdings Ltd.

Perfect Medical Health Management Ltd.

C-MER Eye Care Holdings Ltd.

Jinxin Fertility Group Ltd.

MedSci Healthcare Holdings Ltd.

New Horizon Health Ltd.

Arrail Group Ltd.

JD Health International, Inc.

ClouDr Group Ltd.

Yunkang Group Ltd.

Why is MedSci Healthcare Holdings Ltd. ?

High Debt company with Weak Long Term Fundamental Strength

High Debt Company with a Debt to Equity ratio (avg) at times

Flat results in Jun 25

With ROE of 0.24%, it has a Very Expensive valuation with a 0.80 Price to Book Value

Over the past year, while the stock has generated a return of 4.24%, its profits have risen by 393%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is MedSci Healthcare Holdings Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

MedSci Healthcare Holdings Ltd.

4.24%

-0.82

63.95%

Hang Seng Hong Kong

8.25%

0.41

19.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.00%

EBIT Growth (5y)

0.00%

EBIT to Interest (avg)

0.19

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-1.03

Sales to Capital Employed (avg)

0.24

Tax Ratio

2.08%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

2.30%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

331

Industry P/E

Price to Book Value

0.80

EV to EBIT

17.18

EV to EBITDA

32.55

EV to Capital Employed

8.16

EV to Sales

-1.00

PEG Ratio

Dividend Yield

ROCE (Latest)

47.50%

ROE (Latest)

0.24%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Moving Averages

Bearish (Daily)

KST

Bullish

Dow Theory

Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET PROFIT(HY)

Higher at HKD 5.18 MM

RAW MATERIAL COST(Y)

Fallen by -6.14% (YoY

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for MedSci Healthcare Holdings Ltd.

Net Profit

Higher at HKD 5.18 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Raw Material Cost

Fallen by -6.14% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales